Key facts
- This page summarizes Edward Kovalik's Form 4/A - Amendment filing for Crown Electrokinetics Corp. (CRKN).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 17 Dec 2021, 11:18.
Edward Kovalik - 29 Sep 2021 Form 4/A - Amendment Insider Report for Crown Electrokinetics Corp. (CRKN)
- Reporting relationship
- President and COO, Director
- Issuer ticker
- CRKN
- Reported as of
- 29 Sep 2021
- Net transaction value
- $0
- SEC form
- 4/A - Amendment
- Accepted by SEC
- 17 Dec 2021, 11:18:33 UTC
- Original report date
- 20 Feb 2021
- Next SEC filing
- 05 May 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Edward Kovalik
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Edward Kovalik filed Form 4/A - Amendment for Crown Electrokinetics Corp. (CRKN) on 17 Dec 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CRKN
transaction
Derivative
Restricted Stock Unit
Award
- Transaction value
- Shares
- +400,000
- Change %
- Price
- Shares after
- 400,000
- Date
- 29 Sep 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 400,000
- Exercise price
- Footnotes
- F1, F2, F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Granted pursuant to the Issuer's 2020 Employee Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
Footnote F2
In connection with the Reporting Person's Form 4 filing on February 20, 2021, a grant of 400,000 shares of restricted stock pursuant to the Reporting Person's employment agreement with the Issuer was prematurely disclosed; this disclosed grant was never formalized. This grant of 400,000 restricted stock units was made by the Issuer in satisfaction of the Reporting Person's entitlement to an equity award grant pursuant to his employment agreement with the Issuer.
Footnote F3
77,778 of the restricted stock unit vested on September 29, 2021. Subject to the Reporting Person remaining in continuous service with the Issuer through each applicable vesting date, 11,111 of the restricted stock units will vest monthly for a period of 28 months beginning October 20, 2021, with the remaining 11,114 restricted stock units vesting on February 20, 2024. In the event of a change in control of the Issuer, all then-unvested restricted stock units will vest as of the date of such change in control; if the Reporting Person terminates service with the Issuer as a result of his death, disability or a termination by the Issuer without cause, 100% of the unvested restricted stock units will vest as of the date of such termination. Share of unrestricted Common Stock of the Issuer will be issued with respect to vested restricted stock units on the earliest to occur of (1) February 20, 2026; (2) the Reporting Person's separation from service; (3) a change in control; or (4) the Reporting Person's death.
Footnote F4
Not applicable.